Andrew O Maree1, Desmond J Fitzgerald. Show Affiliations » 1. Division of Cardiology, Harvard Medical School and Massachusetts General Hospital, Boston, Mass, USA.
Abstract
Entities: Chemical Disease
Mesh: See more » Adenosine Diphosphate/physiologyAnti-Inflammatory Agents, Non-Steroidal/adverse effectsAnti-Inflammatory Agents, Non-Steroidal/pharmacologyAnti-Inflammatory Agents, Non-Steroidal/therapeutic useAspirin/adverse effectsAspirin/pharmacologyAspirin/therapeutic useAtherosclerosis/bloodAtherosclerosis/drug therapyBiomarkersBiotransformation/geneticsBlood Coagulation TestsBlood Platelets/drug effectsBlood Platelets/metabolismCardiovascular Diseases/prevention & controlClopidogrelCyclooxygenase 1/physiologyCyclooxygenase Inhibitors/adverse effectsCyclooxygenase Inhibitors/pharmacologyCyclooxygenase Inhibitors/therapeutic useDrug InteractionsDrug Resistance/geneticsHemorrhage/chemically inducedHumansPlatelet Activation/drug effectsPlatelet Activation/physiologyPlatelet Aggregation Inhibitors/adverse effectsPlatelet Aggregation Inhibitors/pharmacologyPlatelet Aggregation Inhibitors/therapeutic usePlatelet Function TestsProspective StudiesRandomized Controlled Trials as TopicReceptors, Purinergic P2/drug effectsReceptors, Purinergic P2/physiologyReceptors, Purinergic P2Y1Receptors, Purinergic P2Y12Thrombosis/bloodThrombosis/drug therapyThromboxane A2/physiologyThromboxane B2/analogs & derivativesThromboxane B2/urineTiclopidine/adverse effectsTiclopidine/analogs & derivativesTiclopidine/pharmacologyTiclopidine/therapeutic useTreatment Failure
Substances: See more » Anti-Inflammatory Agents, Non-SteroidalBiomarkersCyclooxygenase InhibitorsP2RY1 protein, humanP2RY12 protein, humanPlatelet Aggregation InhibitorsReceptors, Purinergic P2Receptors, Purinergic P2Y1Receptors, Purinergic P2Y12Thromboxane B2Thromboxane A2Adenosine Diphosphate11-dehydro-thromboxane B2ClopidogrelCyclooxygenase 1TiclopidineAspirin
Year: 2007 PMID: 17452618 DOI: 10.1161/CIRCULATIONAHA.106.675991
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690